Federal Register proposed rule: FDA proposes to amend its regulations concerning the classification of products as biologics, devices, drugs, or combi...
The University of Illinois at Chicago College of Pharmacy suggests FDA take five steps to speed development and approval of biosimilars.
Three stakeholders raise concerns and questions about FDA-proposed research surveying healthcare professionals on aspects of prescription drug promoti...
Federal Register notice: FDA announces a 7/9 public meeting on Patient-Focused Drug Development for Chronic Pain that is intended to provide patients ...
Federal Register notice: FDA announces a Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee meeting 6/20 to review and discuss ...
FDA warns Indias Reine Lifescience about CGMP deviations in its manufacturing of active pharmaceutical ingredients.
FDA warns Ei LLC about significant violations of CGMP in its manufacturing of finished pharmaceuticals.
FDA asks drug manufacturers to update their PDUFA 6 information and be aware of policy changes under PDUFA.